ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

ALRN Aileron Therapeutics Inc

2.75
-0.02 (-0.72%)
After Hours
Last Updated: 21:05:45
Delayed by 15 minutes
Share Name Share Symbol Market Type
Aileron Therapeutics Inc NASDAQ:ALRN NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.02 -0.72% 2.75 1.11 3.08 2.89 2.60 2.73 38,326 21:05:45

Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)

03/06/2020 9:02pm

Edgar (US Regulatory)


Filed Pursuant to Rule 424(b)(5)

Registration No. 333-226650

PROSPECTUS SUPPLEMENT

(To Prospectus Dated July 15, 2019)

 

LOGO

Common Stock

 

 

This prospectus supplement supplements the prospectus dated July 15, 2019 related to the offer and sale of shares of our common stock, $0.001 par value per share, pursuant to a Capital on Demand Sales Agreement, or the Sales Agreement, dated July 1, 2019, with JonesTrading Institutional Services LLC, or JonesTrading, in “at the market offering” as defined in Rule 415(a)(4) under the Securities Act of 1933. As of the date of this prospectus supplement, we have terminated the offer and sale of shares in at-the-market offerings under the sales agreement prospectus.

As of the date of this prospectus supplement, we had sold an aggregate of 1,263,059 shares of our common stock under the Sales Agreement for aggregate gross proceeds of $762,000.

Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement or the accompanying prospectus. Any representation to the contrary is a criminal offense.

 

 

The date of this prospectus supplement is June 3, 2020.

1 Year Aileron Therapeutics Chart

1 Year Aileron Therapeutics Chart

1 Month Aileron Therapeutics Chart

1 Month Aileron Therapeutics Chart

Your Recent History

Delayed Upgrade Clock